One Person Health Sciences Inc.

One Person Health Sciences Inc.

March 01, 2005 09:01 ET

OPH Announces Major Health Products eCommerce Initiative


NEWS RELEASE TRANSMITTED BY CCNMatthews

FOR: ONE PERSON HEALTH SCIENCES INC.

TSX VENTURE SYMBOL: OPH

MARCH 1, 2005 - 09:01 ET

OPH Announces Major Health Products eCommerce
Initiative

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - March 1, 2005) - One Person
Health Sciences Inc. (TSX VENTURE:OPH) -

OneAdvisor™ links Personalized Health Assessments to Product
Recommendation Agents and Comparison Shopping

Mr. George Fleming, CEO and Founder of One Person Health Sciences Inc.
(OPH), is pleased to introduce the OneAdvisor™, the first Health
Products Recommendation and Comparison Shopping system driven by
personalized Nutritional Health Assessments. The development of the
OneAdvisor™ allows OPH to provide the tens of thousands of consumers
who complete the company's Personal Nutrition Health Assessments with
advisory, recommendation and comparison shopping services currently
unavailable in the market place.

Expanding the company's product offering beyond personalized dietary
supplements, the OneAdvisor™ offers product recommendations matched
from the wide range of quality products carried by leading online
retailers of Nutritional and Health products. Providing the Company with
a unique opportunity to capture market share in an online dietary
supplement market projected by the Nutrition Business Journal to exceed
$740 million in 2005, the OneAdvisor™ also provides comparison
shopping for pharmaceutical and OTC drugs. Jupiter Research has
estimated that the online prescription drug market will see sales of $7
billion in 2005 increasing to $13 billion by 2007.

"The development of the OneAdvisor™ expands OPH's business model
significantly and is a major step forward both for OPH and for the
online health products industry" states Fleming. "Consumers are
demanding that retailers provide them with personalized solutions and an
answer to the question - what should I be taking? The OneAdvisor™
system not only helps consumers answer this question but provides
scientific based product recommendations as well as comparison shopping
features that will find them the best deal."

Assessment based Recommendation and Comparison Shopping Features

A major evolution in expert recommendation and comparison shopping
systems, the OneAdvisor™ system translates personalized Nutrition
Health Assessment results into product recommendations by matching a
recommended dietary supplement formula to groupings of off the shelf
dietary supplement products carried by major online health retailers.
Taking the recommendation system a step further OPH also provides
consumers with industry first comparison shopping features that allows
them to review, sort and compare products by numerous criteria including
price, brand, form of ingredient, animal free, dairy free, gluten free
or yeast free. Once a consumer chooses a product grouping the purchase
is automatically loaded into a shopping cart on the selected health
retailer's site to complete the transaction.

Science Based Nutritional Assessments and Product Recommendations

The new OPH OneAdvisor™ process starts with OPH's proprietary
Personal Nutrition Health Assessment which asks consumers 70 detailed
questions related to their health, diet, lifestyle, medical conditions,
and medications. Built on evidence based scientific research, the OPH
rules engine provides consumers with a free Health Risk Report or one of
OPH's proprietary ONEMed™ health condition reports, four of which
have been launched to date: the ONEMed™ High Cholesterol/Statin
report, the ONEMed™ Cardiovascular Disease Report, the ONEMed™
Arthritis report, and the ONEMed™ High Blood Pressure report.

Each report contains personalized information and advice on therapeutic
diets, lifestyle improvements, exercise, cooking, hydration and
elimination plus a personalized dietary supplement formula designed to
offset health risks and lifestyle concerns. OPH's OneMed™ assessment
reports go a step further. After analyzing the prescriptions currently
being used by an individual, OPH provides up-to-date information on
known interactions and nutrient deficiencies associated with the
selected medications. Each personalized dietary supplement formula
includes supplements that help improve the condition as well as
supplements required to offset the consumer's personal nutrient
deficiencies. Nutrients that must be avoided due to serious
drug-nutrient interactions caused by their medications are removed.

Pharmaceutical & OTC Comparison Shopping - Over 80% of consumers
completing assessments have a Medical Condition or are taking Medications

As a natural extension of the OneAdvisor™ system, OPH also offers
consumers the ability to comparison shop for their pharmaceuticals and
OTC drugs. With over 80% of the consumers who complete a Personal
Nutrition Health Assessment indicating that they have a medical
condition or are taking medications, this added service will provide
useful price comparisons and shopping choices between leading online
pharmacies and health product retailers.

One Person Health (www.onepersonhealth.com) is a leader in the emerging
field of Personalized Nutritional Healthcare. The Company is developing
and commercializing a range of assessment and recommendation products
and services for consumers, health care practitioners, and corporate
partners based on its philosophy of "One Size Does Not Fit All".
Focusing on nutritional analysis and informatics, OPH incorporates
complex nutrition, genetic, drug nutrient interaction, medical
condition, and lifestyle information into its evidence-based health
assessment programs and personalized product recommendations and
offerings.

-30-

Contact Information

  • FOR FURTHER INFORMATION PLEASE CONTACT:
    One Person Health Sciences Inc.
    David Fry
    Corporate Communications
    (604) 301-0221 Ext:113
    dfry@onepersonhealth.com
    The TSX Venture Exchange has not reviewed, and does not accept
    responsibility for the adequacy or accuracy of the content of this news
    release.